Functional domains of the t(8;21) fusion protein, AML-1/ETO - PubMed (original) (raw)
. 1995 Nov 2;11(9):1761-9.
Affiliations
- PMID: 7478604
Functional domains of the t(8;21) fusion protein, AML-1/ETO
N Lenny et al. Oncogene. 1995.
Abstract
The AML-1/ETO fusion protein is created by the (8;21) translocation, the second most frequent chromosomal abnormality associated with acute myeloid leukemia. In the fusion protein the AML-1 runt homology domain, which is responsible for DNA binding and CBF beta interaction, is linked to ETO, a gene of unknown function. The primary sequences of the runt homology domain indicates no known DNA binding motifs, but is predicted to contain six beta-strands, two alpha-helices and a nucleotide binding motif. Mutagenesis of AML-1/ETO was performed to delimit the functional domains of the chimeric protein. Most mutations in the runt homology domain that resulted in reduced CBF beta binding also inhibited DNA binding, indicating that the DNA and CBF beta binding sequences are tightly linked. However, these activities were separated by a point mutation of residue 144, within the putative ATP binding motif, which nearly eliminated DNA binding, but did not affect CBF beta binding. Random mutagenesis identified the hydrophobic face of the amphipathic fifth beta-strand, adjacent to the putative ATP binding motif, as critical for both DNA and CBF beta binding. C-terminal deletion mutants of AML-1/ETO indicated that ETO sequences are essential for interference with AML-1B-mediated transcriptional activation, and that residue 540 defines the C-terminal boundary of a potential repression domain. Thus, these mutational analyses define the regions of AML-1/ETO which regulate its function and that may be important in promoting leukemia.
Similar articles
- AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S, Lenny N, Sun W, Hiebert SW. Meyers S, et al. Oncogene. 1996 Jul 18;13(2):303-12. Oncogene. 1996. PMID: 8710369 - The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F, Pisegna S, Diverio D. Lo Coco F, et al. Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review. - The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC, Sun X, Berguido FJ, Jakubowiak A, Nimer SD. Frank RC, et al. Oncogene. 1999 Mar 4;18(9):1701-10. doi: 10.1038/sj.onc.1202459. Oncogene. 1999. PMID: 10208431 - AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
Licht JD. Licht JD. Oncogene. 2001 Sep 10;20(40):5660-79. doi: 10.1038/sj.onc.1204593. Oncogene. 2001. PMID: 11607817 Review. No abstract available.
Cited by
- AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
Rejeski K, Duque-Afonso J, Lübbert M. Rejeski K, et al. Oncogene. 2021 Sep;40(38):5665-5676. doi: 10.1038/s41388-021-01952-w. Epub 2021 Jul 30. Oncogene. 2021. PMID: 34331016 Free PMC article. Review. - Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H, Debaize L, Soubise B, Avner S, Rouger-Gaudichon J, Commet S, Jiang Y, Sérandour AA, Rio AG, Carroll JS, Wichmann C, Lie-A-Ling M, Lacaud G, Corcos L, Salbert G, Galibert MD, Gandemer V, Troadec MB. Jakobczyk H, et al. J Hematol Oncol. 2021 Mar 20;14(1):47. doi: 10.1186/s13045-021-01051-z. J Hematol Oncol. 2021. PMID: 33743795 Free PMC article. - RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
Zhen T, Cao Y, Ren G, Zhao L, Hyde RK, Lopez G, Feng D, Alemu L, Zhao K, Liu PP. Zhen T, et al. Blood. 2020 Nov 19;136(21):2373-2385. doi: 10.1182/blood.2020007747. Blood. 2020. PMID: 32929473 Free PMC article. - New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.
Li J, Guo C, Steinauer N, Zhang J. Li J, et al. Front Biol (Beijing). 2016 Aug;11(4):285-304. doi: 10.1007/s11515-016-1415-1. Epub 2016 Sep 3. Front Biol (Beijing). 2016. PMID: 28261265 Free PMC article. - RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1.
Ponnusamy K, Kohrs N, Ptasinska A, Assi SA, Herold T, Hiddemann W, Lausen J, Bonifer C, Henschler R, Wichmann C. Ponnusamy K, et al. Oncogenesis. 2015 Apr 13;4(4):e146. doi: 10.1038/oncsis.2015.6. Oncogenesis. 2015. PMID: 25867177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical